Modular Variations of the Human Major Histocompatibility Complex Class III Genes for Serine/Threonine Kinase RP, Complement Component C4, Steroid 21-Hydroxylase CYP21, and Tenascin TNX (the RCCX Module)

The frequent variations of human complement component C4 gene size and gene numbers, plus the extensive polymorphism of the proteins, render C4 an excellent marker for major histocompatibility complex disease associations. As shown by definitive RFLPs, the tandemly arranged genes RP, C4,CYP21, and TNX are duplicated together as a discrete genetic unit termed the RCCX module. Duplications of the RCCX modules occurred by the addition of genomic fragments containing a long (L) or a short (S) C4 gene, a CYP21A or aCYP21B gene, and the gene fragments TNXA andRP2. Four major RCCX structures with bimodular L-L, bimodular L-S, monomodular L, and monomodular S are present in the Caucasian population. These modules are readily detectable byTaqI RFLPs. The RCCX modular variations appear to be a root cause for the acquisition of deleterious mutations from pseudogenes or gene segments in the RCCX to their corresponding functional genes. In a patient with congenital adrenal hyperplasia, we discovered aTNXB-TNXA recombinant with the deletion ofRP2-C4B-CYP21B. Elucidation of the DNA sequence for the recombination breakpoint region and sequence analyses yielded definitive proof for an unequal crossover betweenTNXA from a bimodular chromosome and TNXB from a monomodular chromosome.

[1]  S. Gitelman,et al.  Tenascin-X: a novel extracellular matrix protein encoded by the human XB gene overlapping P450c21B , 1993, The Journal of cell biology.

[2]  P. White,et al.  Structure of human steroid 21-hydroxylase genes. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[3]  J. Bristow,et al.  Sequences promoting the transcription of the human XA gene overlapping P450c21A correctly predict the presence of a novel, adrenal-specific, truncated form of tenascin-X. , 1995, Genomics.

[4]  F. Sanger,et al.  DNA sequencing with chain-terminating inhibitors. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[5]  P. Schneider,et al.  Length polymorphism of the human complement component C4 gene is due to an ancient retroviral integration. , 1995, Experimental and clinical immunogenetics.

[6]  C. Y. Yu,et al.  Four ubiquitously expressed genes, RD (D6S45)-SKI2W (SKIV2L)-DOM3Z-RP1 (D6S60E), are present between complement component genes factor B and C4 in the class III region of the HLA. , 1998, Genomics.

[7]  M. Satake,et al.  Human histocompatibility leukocyte antigen (HLA) haplotype frequencies estimated from the data on HLA class I, II, and III antigens in 111 Japanese narcoleptics. , 1985, The Journal of clinical investigation.

[8]  C. Alper,et al.  Inherited structural polymorphism of the fourth component of human complement. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[9]  R. Campbell,et al.  The G11 Gene Located in the Major Histocompatibility Complex Encodes a Novel Nuclear Serine/Threonine Protein Kinase* , 1998, The Journal of Biological Chemistry.

[10]  W. Westerhof,et al.  Molecular heterogeneity of the fourth component of complement (C4) and its genes in vitiligo. , 1992, The Journal of investigative dermatology.

[11]  J. Bristow,et al.  Tenascin–X deficiency is associated with Ehlers–Danlos syndrome , 1997, Nature Genetics.

[12]  J. Volanakis,et al.  Individuals with IgA deficiency and common variable immunodeficiency share polymorphisms of major histocompatibility complex class III genes. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[13]  O. Gotoh,et al.  Complete nucleotide sequence of two steroid 21-hydroxylase genes tandemly arranged in human chromosome: a pseudogene and a genuine gene. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[14]  S. Gitelman,et al.  Transcript encoded on the opposite strand of the human steroid 21-hydroxylase/complement component C4 gene locus. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[15]  P. Schneider,et al.  Genetic basis of human complement C4A deficiency. Detection of a point mutation leading to nonexpression. , 1993, The Journal of clinical investigation.

[16]  T. Strachan,et al.  Genesis by meiotic unequal crossover of a de novo deletion that contributes to steroid 21-hydroxylase deficiency. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[17]  A. Willis,et al.  The reaction mechanism of the internal thioester in the human complement component C4 , 1996, Nature.

[18]  C. Y. Yu,et al.  The human DEVH-box protein Ski2w from the HLA is localized in nucleoli and ribosomes. , 1998, Nucleic acids research.

[19]  H. Colten,et al.  Polymorphism of the human complement C4 and steroid 21-hydroxylase genes. Restriction fragment length polymorphisms revealing structural deletions, homoduplications, and size variants. , 1986, The Journal of clinical investigation.

[20]  R. Campbell,et al.  Characterisation of the novel gene G11 lying adjacent to the complement C4A gene in the human major histocompatibility complex. , 1994, Human molecular genetics.

[21]  A. McMichael,et al.  HLA and MHC: Genes, Molecules And Function , 1997, Nature Medicine.

[22]  L. Strong,et al.  Human C4 haplotypes with duplicated C4A or C4B. , 1984, American journal of human genetics.

[23]  D. Bentley,et al.  A molecular map of the human major histocompatibility complex class III region linking complement genes C4, C2 and factor B , 1984, Nature.

[24]  Robert B Sim,et al.  Complement : a practical approach , 1997 .

[25]  E. Choi,et al.  Molecular genetics of C4B deficiency in IgA nephropathy. , 1989, Human immunology.

[26]  A. Burghes.  When is a deletion not a deletion? When it is converted. , 1997, American journal of human genetics.

[27]  G M Edelman,et al.  A cDNA clone for cytotactin contains sequences similar to epidermal growth factor-like repeats and segments of fibronectin and fibrinogen. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[28]  F. Jenhani,et al.  C4 polymorphism in multiplex families with insulin dependent diabetes in the Tunisian population: standard C4 typing methods and RFLP analysis. , 1992, Journal of autoimmunity.

[29]  A Ando,et al.  Cluster of fibronectin type III repeats found in the human major histocompatibility complex class III region shows the highest homology with the repeats in an extracellular matrix protein, tenascin. , 1992, Genomics.

[30]  P. Donohoue,et al.  The HLA-A3, Cw6,B47,DR7 extended haplotypes in salt losing 21-hydroxylase deficiency and in the Old Order Amish: identical class I antigens and class II alleles with at least two crossover sites in the class III region. , 1995, Tissue antigens.

[31]  P. Dyer,et al.  HLA and MHC: Genes, molecules and function , 1997 .

[32]  P. Donohoue,et al.  Prevalence of polymorphic 21-hydroxylase gene (CA21HB) mutations in salt-losing congenital adrenal hyperplasia. , 1987, Biochemical and biophysical research communications.

[33]  Thomas J. White,et al.  PCR protocols: a guide to methods and applications. , 1990 .

[34]  P. Schneider,et al.  C4 reference typing report. , 1990, Complement and inflammation.

[35]  C. Lewis,et al.  Correlation of SMNt and SMNc gene copy number with age of onset and survival in spinal muscular atrophy , 1998, European Journal of Human Genetics.

[36]  A. Ahmed,et al.  Major histocompatibility complex haplotypes and class II genes in non-Jewish patients with pemphigus vulgaris. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[37]  K. Belt,et al.  The structural basis of the multiple forms of human complement component C4 , 1984, Cell.

[38]  M. Carroll,et al.  Substitution of a single amino acid (aspartic acid for histidine) converts the functional activity of human complement C4B to C4A. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[39]  M. Walport,et al.  Family study of the major histocompatibility complex in patients with systemic lupus erythematosus: importance of null alleles of C4A and C4B in determining disease susceptibility. , 1983, British medical journal.

[40]  L. Truedsson,et al.  Relationship between protein complotypes and DNA variant haplotypes: complotype-RFLP constellations (CRC). , 1997, Human immunology.

[41]  R. Campbell,et al.  Structural basis of the polymorphism of human complement components C4A and C4B: gene size, reactivity and antigenicity. , 1986, The EMBO journal.

[42]  M. Tusié-Luna,et al.  Gene conversions and unequal crossovers between CYP21 (steroid 21-hydroxylase gene) and CYP21P involve different mechanisms. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[43]  E. Hay,et al.  Guidebook to the extracellular matrix and adhesion proteins , 1995 .

[44]  Yves Morel,et al.  The molecular genetics of 21-hydroxylase deficiency. , 1989, Annual review of genetics.

[45]  M. Steinmetz,et al.  A previously undetected MHC gene with an unusual periodic structure. , 1988, Science.

[46]  Benjamin Lewin,et al.  Genes for SMA: Multum in parvo , 1995, Cell.

[47]  M. Petzl-Erler,et al.  Major histocompatibility complex (MHC) class III genetics in two Amerindian tribes from Southern Brazil: the Kaingang and the Guarani , 1997, Human Genetics.

[48]  K. Belt,et al.  Deletion of complement C4 and steroid 21‐hydroxylase genes in the HLA class III region. , 1985, The EMBO journal.

[49]  C. Y. Yu,et al.  Molecular Genetics of the Human MHC Complement Gene Cluster , 1999, Experimental and Clinical Immunogenetics.

[50]  P. Schneider,et al.  Identification of the recombination site within the steroid 21-hydroxylase gene (CYP21) of the HLA-B47,DR7 haplotype. , 1992, Experimental and clinical immunogenetics.

[51]  T. Sasazuki,et al.  Gene conversion-like events cause steroid 21-hydroxylase deficiency in congenital adrenal hyperplasia. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[52]  J. Klein,et al.  Molecular Evolution of the Major Histocompatibility Complex , 2011, NATO ASI Series.

[53]  H. Colten,et al.  Deficiency of human complement protein C4 due to identical frameshift mutations in the C4A and C4B genes. , 1999, Journal of immunology.

[54]  C. Y. Yu,et al.  The complete exon-intron structure of a human complement component C4A gene. DNA sequences, polymorphism, and linkage to the 21-hydroxylase gene. , 1991, Journal of immunology.

[55]  I. Dunham,et al.  Molecular characterization of the HLA‐linked steroid 21‐hydroxylase B gene from an individual with congenital adrenal hyperplasia. , 1987, The EMBO journal.

[56]  S. Gitelman,et al.  Mechanism and consequences of the duplication of the human C4/P450c21/gene X locus , 1992, Molecular and cellular biology.

[57]  J. M. Porcel-Pérez,et al.  [Complement in inflammation]. , 1996, Revista clinica espanola.

[58]  E. Sim,et al.  Phenotyping of human complement component C4, a class-III HLA antigen. , 1986, The Biochemical journal.

[59]  M. Tassabehji,et al.  Identification of a novel family of human endogenous retroviruses and characterization of one family member, HERV-K(C4), located in the complement C4 gene cluster. , 1994, Nucleic acids research.

[60]  C. Y. Yu,et al.  Structure and genetics of the partially duplicated gene RP located immediately upstream of the complement C4A and the C4B genes in the HLA class III region. Molecular cloning, exon-intron structure, composite retroposon, and breakpoint of gene duplication. , 1994, The Journal of biological chemistry.